Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Lotte is a Scientific Vice President in Global Research at Novo Nordisk in Denmark. She is a chemist by training, has a doctoral degree in scientific medicine and has worked for Novo Nordisk for 30 years. She is a recognised expert of GLP-1 based drug discovery and mechanism of action studies in diabetes, obesity and toxicology. Her research focuses on drug discovery, receptor expression, molecular pharmacology, in vivo pharmacology, mechanistic toxicology and mechanism of action of drugs in obesity and diabetes, and has resulted in app. 70 peer-reviewed original papers.
